Solicitation 2024 - POCTRN
POCTRN 2024
Do you have a groundbreaking point-of-care technology in need of development?
The National Institute of Biomedical Imaging and Bioengineering’s (NIBIB) Point-of-Care Technology Research Network (POCTRN) is pleased to announce six new funding opportunities from its centers.
Advance the development of your transformative point-of-care technology through collaborative efforts that seamlessly blend scientific and technological expertise with clinical needs.
Don't miss this chance to propel your innovation forward!
The deadline for this opportunity has passed.
Timeline
Solicitation Release: February 20, 2024
Expression of Interest Due: March 31, 2024 11:59PM ET
Invitations for Full Proposals: April 29, 2024
Full Proposals Due: June 2, 2024, 11:59PM ET
Notification of Successful Applicants: August 5, 2024
Center for Point of Care Technologies for Nutrition, Infection, and Cancer in Global Health at Cornell University
Support the development of Point-of-Care Technologies in Nutrition, Infection, and Cancer for Global Health
Center for Innovation and Translation of Point of Care Technologies for Equitable Cancer Care
Point-of-Care Tools to Improve Detection of Pre-Cancer and Early Cancer in Medically Under-Served Settings
Atlanta Center for Microsystems Engineered Point-of-Care Technologies
ACME POCT Call for Proposals for Microsystems-based Point-of-Care Technologies
Johns Hopkins Center for Innovative Diagnostics for Infectious Diseases
Improvements To Rapid Simple Point-Of-Care Tests For Sexually Transmitted Infections (STIs)
Center for Advancing Point of Care in Heart, Lung, Blood, and Sleep Diseases
Focused on developing, adapting, or validating point of care technologies that can be rapidly applied to heart, lung, blood, or sleep disorders, with additional interest in projects that incorporate complementary and integrative health approaches.
Center for Innovation in Point-of-Care Technologies for HIV/AIDS and Emerging Infectious Diseases at Northwestern
Point-of-Care Technologies for HIV/AIDS, Co-morbidities, and Emerging Infectious Disease in Low- and Middle-Income Countries